Evidence map›Paper›PMID 27600683›Full record

ReviewBMC medicine2016

Post-mortem assessment in vascular dementia: advances and aspirations.

Kirsty E McAleese, Irina Alafuzoff, Andreas Charidimou, Jacques De Reuck, Lea T Grinberg, Atticus H Hainsworth, Tibor Hortobagyi, Paul Ince, Kurt Jellinger, Jing Gao and 11 more

Open access · goldAbstract readReview
In one paragraph

Review in BMC medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Neuropathology in a diverse cohort of oldest-old: The LifeAfter90 study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Review
  4. Article
  5. The enigma of vascular dementia: current state and emerging perspectives.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 12 countries.

Kirsty E McAleeseInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Irina AlafuzoffDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Andreas CharidimouHemorrhagic Stroke Research Program, Department of Neurology, Massachusetts General Hospital Stroke Research Center, Harvard Medical School, Boston, MA, USA.
Jacques De ReuckStroke Research Team, University Hospital Lille, Lille, France.
Lea T GrinbergDepartments of neurology and Pathology, University of California, San Francisco, USA.
Atticus H HainsworthInstitute of Cardiovascular and Cell Sciences, St George's University of London, London, UK.
Tibor HortobagyiDepartment of Neuropathology, University of Debrecen, Debrecen, Hungary.
Paul InceSheffield Institute for Translational Neuroscience, Sheffield, UK.
Kurt JellingerInstitute of Clinical Neurobiology, Vienna, Austria.
Jing GaoNeurological Department, Peking Union Medical College Hospital, Beijing, China.
Raj N KalariaInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Gabor G KovacsInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Enikö KövariDepartment of Mental Health and Psychiatry, University of Geneva, Geneva, Switzerland.
Seth LoveClincial Neurosciences, University of Bristol, Bristol, UK.
Mara PopovicInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Olivia SkrobotClincial Neurosciences, University of Bristol, Bristol, UK.
Ricardo TaipaUnit of Neuropathology, Centro Hospitalar do Porto, University of Porto, Porto, Portugal.
Dietmar R ThalDepartment of Neuroscience, KU-Leuven and Department of Pathology, UZ-Leuven, Leuven, Belgium.
David WerringInstitute of Neurology, University College London, London, UK.
Stephen B WhartonSheffield Institute for Translational Neuroscience, Sheffield, UK.
Johannes AttemsInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK. Johannes.Attems@ncl.ac.uk.
Newcastle University · GBUniversity of Bristol · GBUniversity of Sheffield · GBLille’s Cardiology Hospital · FRMassachusetts General Hospital · USMedical University of Vienna · ATPeking Union Medical College Hospital · CNSt George's, University of London · GBUniversidade do Porto · PTUniversitair Ziekenhuis Leuven · BEUniversity College London · GBUniversity of California, San Francisco · USUniversity of Debrecen · HUUniversity of Geneva · CHUniversity of Ljubljana · SIUppsala University · SE

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
Brainstem as an early site in AD and FTLD: closing the etiopathogenic gapR01AG040311 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRINBERG, LEA TENENHOLZ · 2011 to 2015
$2.0M
Alzheimer's Society 151Medical Research Council G0400074Medical Research Council G0500247Medical Research Council G0502157Medical Research Council G0900652Medical Research Council G1100540Medical Research Council MC_PC_14095National Centre for the Replacement, Refinement and Reduction of Animals in Research G0800701/1NIA NIH HHS P01 AG019724NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG040311
6 · The paper itself

Abstract

backgroundCerebrovascular lesions are a frequent finding in the elderly population. However, the impact of these lesions on cognitive performance, the prevalence of vascular dementia, and the pathophysiology behind characteristic in vivo imaging findings are subject to controversy. Moreover, there are no standardised criteria for the neuropathological assessment of cerebrovascular disease or its related lesions in human post-mortem brains, and conventional histological techniques may indeed be insufficient to fully reflect the consequences of cerebrovascular disease. DISCUSSION: Here, we review and discuss both the neuropathological and in vivo imaging characteristics of cerebrovascular disease, prevalence rates of vascular dementia, and clinico-pathological correlations. We also discuss the frequent comorbidity of cerebrovascular pathology and Alzheimer's disease pathology, as well as the difficult and controversial issue of clinically differentiating between Alzheimer's disease, vascular dementia and mixed Alzheimer's disease/vascular dementia. Finally, we consider additional novel approaches to complement and enhance current post-mortem assessment of cerebral human tissue.

conclusionElucidation of the pathophysiology of cerebrovascular disease, clarification of characteristic findings of in vivo imaging and knowledge about the impact of combined pathologies are needed to improve the diagnostic accuracy of clinical diagnoses.

Indexed as

AgedAlzheimer DiseaseAutopsyBrainCerebrovascular DisordersComorbidityDementiaDementia, VascularHumansPrevalenceCerebrovascular diseaseCerebrovascular lesionsMagnetic resonance imagingMixed dementiaNeuropathologyPost-mortem MRIVascular cognitive impairmentVascular dementia

Identifiers

PMID27600683
PMCPMC5011905
OpenAlexW2514506319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.